About This ReportThis new 280-page report from VPGMarketResearch presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts, the report:-  Examines market applications of Molecular Diagnostics,     Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;-  Reviews features and operating characteristics of major analyzers used    for STD testing;-  Profiles key suppliers and potential market entrants developing innovative   technologies and products; and-  Analyzes emerging opportunities, alternative market penetration strategies,    market entry barriers/risks, and strategic planning issues.Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative... Research Beam Model: Research Beam Product ID: 328844 0 USD New
2015-2019 Spain Sexually-Transmitted Diseases (STD) Diagnostic Testing Market: Supplier Shares and Country Forecasts

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015-2019 Spain Sexually-Transmitted Diseases (STD) Diagnostic Testing Market: Supplier Shares and Country Forecasts

 
  • Category : Diagnostic and Biotech
  • Published On : September  2015
  • Pages : 280
 
 

About This Report

This new 280-page report from VPGMarketResearch presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.    

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used
   for STD testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies,
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.
 
Contains 280 pages and 16 tables